Relief Therapeutics Holding AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Relief Therapeutics Holding AG generated cash of -$17,612,000, which is more than the previous year. Cash used in financing activities reached the amount of $4,050,000 last year. Net change in cash is therefore -$4,681,000.
Cash Flow
| 2014 | -8.73M | -585.58K | 13.41M |
|---|---|---|---|
| 2015 | -6.66M | 1.09M | 2.27M |
| 2016 | -2.88M | 125K | 3.14M |
| 2017 | -1.17M | 0 | 914K |
| 2018 | -618K | 0 | 748K |
| 2019 | -748K | 0 | 620K |
| 2020 | -18.23M | 3.00M | 58.18M |
| 2021 | -35.71M | -30.26M | 67.68M |
| 2022 | -24.10M | -8.01M | 6.41M |
| 2023 | -17.61M | 8.69M | 4.05M |
RLF.SW Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 19.23M | 44.76M | 43.15M | 129K | 265K | 135K | 394K | 13K | 4.49M | 929.47K |
Operating activities | ||||||||||
Net income | -98.18M | -50.79M | -34.70M | -7.82M | -7.46M | -436K | -2.88M | -16.83M | -9.15M | -12.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.31M | 3.86M | 2.03M | 112K | 1K | 17K | 3K | 10K | 2.11M | 2.32M |
Stock-based compensation expense | 814K | 2.18M | 1.14M | 1.04M | 0 | 0 | 70K | 91K | 1.77M | 0 |
| Deferred income tax benefit | 814K | 2.18M | 1.14M | 1.04M | 0 | 0 | 70K | 91K | 1.77M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 129K | -19K | -208K | 0 | 0 | 0 | 2K | -16K | 1.85M | 0 |
Inventories | -330K | 164K | -111K | 0 | 0 | 0 | -442K | 0 | 14.04K | 3.60K |
Accounts payable | -599K | -75K | -823K | 1.16M | 225K | -369K | 110K | -301K | -1.07M | 0 |
Cash generated by operating activities | -17.61M | -24.10M | -35.71M | -18.23M | -748K | -618K | -1.17M | -2.88M | -6.66M | -8.73M |
Investing activities | ||||||||||
Purchases Of Investments | -5K | -38K | -23K | 0 | 0 | 0 | 0 | -136K | 0 | 0 |
Investments In Property Plant And Equipment | -446K | -521K | -13.70M | 0 | 0 | 0 | 0 | -11K | -479.81K | -874.16K |
Acquisitions Net | 0 | -7.92M | -16.67M | -16K | 0 | 0 | 0 | 132K | 0 | 0 |
Cash generated by investing activities | 8.69M | -8.01M | -30.26M | 3.00M | 0 | 0 | 0 | 125K | 1.09M | -585.58K |
Financing activities | ||||||||||
Common Stock Issued | 5.09M | 7.11M | 76.08M | 58.33M | 0 | 748K | 1.05M | 3.07M | 1.01M | 14.92M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -2.84M | -634K | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -550K | -471K | -5.55M | -480K | 0 | 0 | 0 | 0 | 1.25M | -1.52M |
Cash used in financing activities | 4.05M | 6.41M | 67.68M | 58.18M | 620K | 748K | 914K | 3.14M | 2.27M | 13.41M |
Net Change In Cash | -4.68M | -25.52M | 1.60M | 43.02M | -136K | 130K | -259K | 381K | -3.30M | 4.07M |
Cash at end of period | 14.55M | 19.23M | 44.76M | 43.15M | 129K | 265K | 135K | 394K | 1.19M | 5.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |